Volgen
R.A. Alingh
R.A. Alingh
MSc
Geverifieerd e-mailadres voor umcg.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB. nl: The PharmLines initiative
R Sediq, J Van Der Schans, A Dotinga, RA Alingh, B Wilffert, JHJ Bos, ...
Clinical epidemiology, 981-989, 2018
672018
Exergaming for elderly: effects of different types of game feedback on performance of a balance task
CJC Lamoth, R Alingh, SR Caljouw
Annual Review of Cybertherapy and Telemedicine 2012, 103-107, 2012
602012
Protocol of a longitudinal cohort study on physical activity behaviour in physically disabled patients participating in a rehabilitation counselling programme: ReSpAct
RA Alingh, F Hoekstra, CP van der Schans, FJ Hettinga, R Dekker, ...
BMJ open 5 (1), e007591, 2015
472015
Design of a process evaluation of the implementation of a physical activity and sports stimulation programme in Dutch rehabilitation setting: ReSpAct
F Hoekstra, RA Alingh, CP van der Schans, FJ Hettinga, M Duijf, R Dekker, ...
Implementation science 9, 1-12, 2014
392014
The current implementation status of the integration of sports and physical activity into Dutch rehabilitation care
F Hoekstra, FJ Hettinga, RA Alingh, M Duijf, R Dekker, ...
Disability and Rehabilitation 39 (2), 181-186, 2017
92017
Handboek Revalidatie, Sport en Bewegen
L Schijvens, RA Alingh, M Duijf, F Hoekstra, H Leutscher
Bunnik: Stichting Onbeperkt Sportief, 2014
72014
A questionnaire to assess rehabilitation patients’ experiences with motivational interviewing consultation in the context of physical activity stimulation
T Hoekstra, RA Alingh, HS de Vries, R Bes, F Hoekstra, ...
Disability and Rehabilitation 42 (15), 2198-2203, 2020
22020
Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive …
MA Bahar, JHJ Bos, SD Borgsteede, A Dotinga, RA Alingh, B Wilffert, ...
Frontiers in Pharmacology 11, 624, 2020
22020
Prevalentie van risicofactoren voor hart-en vaatziekten op basis van het Lifelines cohort
A Sijtsma, RA Alingh, MY van der Ende, HT Hartman, P van der Harst, ...
de Boer AR, van Dis I, Visseren FLJ, Vaartjes I, Bots ML. Hart-en …, 2018
12018
Background: Drug-drug interaction (DDI) is one of the main contributors to adverse drug reactions and therefore, it is important to study its frequency in the population. We …
MA Bahar, JHJ Bos, SD Borgsteede, A Dotinga, RA Alingh, B Wilffert, ...
Big Data, Pharmacogenomics and Real-World Research in Pharmacology, 2020
2020
Burden and concordance of information on CYP2D6, CYP2C19, AND CYP2C9 related substrate and inhibitor co-prescriptions from the lifelines cohort: the Pharmlines initiative
MA Bahar, JHJ Bos, SD Borgsteede, A Dotinga, RA Alingh, B Wilffert, ...
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 121-121, 2019
2019
The Added Value of an Exergaming Component in Executing a Balance Task on a Wobble Board for bothYoung Adults and Elderly
R Alingh
2012
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–12